|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2025―Feb―09 |
Comment on “Delta and Omicron SARS-CoV-2 pneumonia: Comparison of clinical and radiological features” |
Hinpetch Daungsupawong, Viroj Wiwanitkit |
2 |
[GO] |
2025―Jan―23 |
Delta and Omicron SARS-CoV-2 pneumonia: Comparison of clinical and radiological features |
Jonathan Pehlivan, Pierre Berge, Anne-Laurence Gourdier, Michael Phelippeau, Pierre Danneels, Rafael Mahieu, Vincent Dubée |
3 |
[GO] |
2025―Jan―11 |
Introduction of molecular point-of-care testing for SARS-CoV-2 in a triage unit of a large maternity hospital: An evaluation of staff experiences |
M. Howarth-Maddison, I.N. Okoliegbe, N.EL Sakka |
4 |
[GO] |
2024―Sep―20 |
The effects of the SARS-CoV-2 pandemic on the delivery of maternal and child health services in South Africa |
Ellen Iileka, Maryke Geldenhuys, Juliet Charity Yauka Nyasulu |
5 |
[GO] |
2024―Sep―07 |
Consequences of at-risk surgery in patients with SARS-CoV-2 infection |
Fatou Niang, Guillaume Ménard, Bay Karim Diallo, Birame Loum, Richard Edouard Alain Deguenonvo, Vincent Thibault, Pierre Tattevin |
6 |
[GO] |
2024―Aug―03 |
Discussion on ‘External validation of two clinical prediction models for mortality in COVID-19 patients (4C and NEWS2), in three centers in Medellín, Colombia: Assessing the impact of vaccination over time’ |
Hai-Feng Liu, Hong-Min Fu |
7 |
[GO] |
2024―Jul―02 |
Supply of nirmatrelvir/ritonavir and molnupiravir for patients with COVID-19 in the first eight months since listing on the Australian Pharmaceutical Benefits Scheme: A retrospective observational study |
Derrick Lopez, Douglas Pritchard, Frank M. Sanfilippo, Erin Kelty, Amy Page, Christopher Etherton-Beer, et al. (+2) Osvaldo P. Almeida, David B. Preen |
8 |
[GO] |
2024―Jun―26 |
Contributions of the qualitative Qualicor study embedded in a cohort study on the circumstances of SARS-CoV 2 infection in France |
Christophe Perrey, Alexandra Mailles, Alexandra Septfons, Tiffany Charmet, Olivia Cheny, Cassandre Von Platen, et al. (+5) Pauline Huet, Daniel Lévy-Bruhl, Simon Galmiche, Arnaud Fontanet, Marie Jauffret-Roustide |
9 |
[GO] |
2024―May―03 |
External validation of two clinical prediction models for mortality in COVID-19 patients (4C and NEWS2), in three centers in Medellín, Colombia: Assessing the impact of vaccination over time |
Paola Andrea Gallego Aristizabal, Tania Paola Lujan Chavarría, Sara Isabel Vergara Hernández, Federico Rincón Acosta, María Paula Sánchez Carmona, Paula Andrea Salazar Ospina, et al. (+3) Carlos Jose Atencia Florez, Carlos Mario Barros Liñán, Fabián Jaimes |
10 |
[GO] |
2024―Apr―17 |
Is there an interest in systematic serum screening for aspergillosis in COVID-19 patients in a medical ward? |
Victor Gerber, Louis Boehn, Marcela Sabou, Antoine Studer, Axel Ursenbach, Yves Hansmann, et al. (+4) Raoul Herbrecht, Nicolas Lefebvre, Valérie Letscher-Bru, François Danion |
11 |
[GO] |
2024―Mar―16 |
Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination |
Christine Durier, Laetitia Ninove, Sylvie van der Werf, Maeva Lefebvre, Corinne Desaint, Rebecca Bauer, et al. (+21) Mikael Attia, Anne-Sophie Lecompte, Marie Lachatre, Zoha Maakaroun-Vermesse, Jean-François Nicolas, Renaud Verdon, Jean-Jacques Kiladjian, Paul Loubet, Catherine Schmidt-Mutter, Violaine Corbin, Séverine Ansart, Giovanna Melica, Martine Resch, Emmanuelle Netzer, Yousra Kherabi, Raphaëlle Tardieu, Jean-Daniel Lelièvre, Eric Tartour, Laurence Meyer, Xavier de Lamballerie, Odile Launay |
12 |
[GO] |
2024―Mar―16 |
One-year follow-up of COVID-19 recoverees with impaired pulmonary function: A prospective cohort study |
Nitzan Karny Epstein, Dana Yelin, Dorit Shitenberg, Dafna Yahav, Leonard Leibovici, Vered Daitch, Ili Margalit |
13 |
[GO] |
2024―Feb―02 |
Change of epidemiological characteristics of four respiratory viral infections in children before and during COVID-19 pandemic |
Dan Xu, Zhimin Chen, Guohong Zhu |
14 |
[GO] |
2024―Feb―02 |
Assessment of the predictive value of plasma calprotectin in the evolution of SARS-Cov-2 primo-infection |
Gauthier Lignier, Caroline Camaré, Thibaut Jamme, Marie-Sophie Combis, Didier Tayac, Françoise Maupas-Schwalm |
15 |
[GO] |
2023―Nov―18 |
Could the changes of immunity induced by SARS-CoV-2 infections explain the rebound of infectious disease after the relaxation of non-pharmaceutical interventions? |
Robert Cohen, Corinne Levy |
16 |
[GO] |
2023―Nov―15 |
Clinical Features and Outcomes in Adults with COVID-19 during the pre-Omicron and Omicron Waves |
M. Martinot, A. Schieber, J.C. Ongagna, A. Henric, M. Eyriey, M. Mohseni-Zadeh, et al. (+4) C. Ion, K demesmay, S. Gravier, C. Kempf |
17 |
[GO] |
2023―Nov―14 |
The outbreak of seasonal influenza after the COVID-19 pandemic in China: Unraveling the “Immunity debt” |
Qingchun Pan, Xiaohua Chen, Yongsheng Yu, Guoqing Zang, Zhenghao Tang |
18 |
[GO] |
2023―Nov―10 |
The importance of COVID-19 vaccination during lactation |
Maria Isabel Valverde-Merino, Manuel Gomez-Guzman, Celia Piquer-Martinez, Maria Dolores Cabezas Lopez, Maria Jose Zarzuelo |
19 |
[GO] |
2023―Sep―09 |
Long-term complications after infection with SARS-CoV-1, influenza and MERS-CoV - lessons to learn in long COVID? |
F.B. Løkke, K.S. Hansen, L.S. Dalgaard, K. Öbrink-Hansen, B. Schiøttz-Christensen, S. Leth |
20 |
[GO] |
2023―Aug―10 |
Diagnostic accuracy of a rapid antigen triple test (SARS-CoV-2, respiratory syncytial virus, and influenza) using anterior nasal swabs versus multiplex RT-PCR in children in an emergency department |
Salim Ferrani, Thierry Prazuck, Stéphane Béchet, Fabien Lesne, Robert Cohen, Corinne Levy |
21 |
[GO] |
2023―Jul―14 |
Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19 |
Nadir Arber, Pallav L Shah, Lambert Assoumou, Casper Rokx, Nathalie De Castro, Ameet Bakhai, et al. (+13) Alex Soriano Viladomiu, Lourdes Mateu, Carlos Lumbreras, Vicente Estrada, Adrian Curran, Pierre-Olivier Sellier, Annie Duffy, Carl Fletcher, Essy Mozaffari, Richard Haubrich, Paul Hodgkins, Anton Pozniak, Francois Raffi |
22 |
[GO] |
2023―Jul―14 |
Medical treatment for Covid-19 - three years later |
François Trémolières |
23 |
[GO] |
2023―Jul―03 |
Long COVID sexual dysfunction among both genders: evaluation of a cohort of COVID-19 recoverees |
Dana Yelin, Vered Daitch, Talya Kalfon, Michal Mor, Shira Buchrits, Yair Shafir, et al. (+6) Muhammad Awwad, Nassem Ghantous, Irit Shapira-Lichter, Leonard Leibovici, Dafna Yahav, Ili Margalit |
24 |
[GO] |
2023―May―17 |
External validation of the Oldham Composite Covid-19 associated Mortality Model (OCCAM), a prognostic model for death in patients hospitalised with Covid-19 |
J.V. Thompson, J.M. Clark, T. Fincham, R. Harkness, N.J. Meghani, B.M. Powell, et al. (+2) D. McLeneghan, G. Ng Man Kwong |
25 |
[GO] |
2023―Apr―26 |
Prospective cohort of COVID-19 patients requiring hospital admission in Douala, Cameroon |
S. Tchamgoué, M. Ntep Eboko, A. Makamté, A. Ngagnia, F. Talla-Mba, O. Nitcheu Wendi, et al. (+4) E. Kafando, B. Tengang, J.P. Sandjon, P. Tattevin |
26 |
[GO] |
2023―Apr―11 |
Lesson from the COVID-19 pandemic lockdown: A major change of hospital-diagnosed bacteremia epidemiology |
Vincent Cauhapé, Brigitte Lamy, Romain Lotte, Irit Touitou, Laurent Boyer, Julie Contenti, et al. (+4) François Parisot, Raymond Ruimy, Michel Carles, Johan Courjon |
27 |
[GO] |
2023―Mar―22 |
Risk factors for nosocomial COVID-19 in a French university hospital |
C Dinh, M Gallouche, H Terrisse, K Gam, C Giner, B Nemoz, et al. (+4) S Larrat, J Giai, JL Bosson, C Landelle |
28 |
[GO] |
2023―Mar―01 |
Emergence and Evolution of the Omicron SARS-CoV-2 Variant in the Island of Martinique |
GN Gbaguidi, L Aubert, J Schaeffer, L Fagour, A Dubremetz, Vincent Enouf, et al. (+4) M-Hélène Glaudon-Louveau de la Guigneraye, F Nestour, J Rosine, G Dos-Santos |
29 |
[GO] |
2023―Feb―28 |
COVID-19 long-term sequelae: Omicron versus Alpha and Delta variants |
Ana Hernández-Aceituno, Abigail García-Hernández, Eneko Larumbe-Zabala |
30 |
[GO] |
2023―Feb―25 |
Twelve-month follow-up after hospitalization for SARS-COV-2: physiology improves, symptoms remain |
Søren Sperling, Steffen Leth, Andreas Fløe, Charlotte Hyldgaard, Tina Gissel, Ayfer Topcu, et al. (+5) Lars Kristensen, Lene Sønderskov Dahl, Johannes Martin Schmid, Søren Jensen-Fangel, Elisabeth Bendstrup |
31 |
[GO] |
2023―Feb―11 |
Symptoms of Long-COVID 1-Year After a COVID-19 Outbreak Among Sailors on a French Aircraft Carrier |
Anne Perisse, François De Cacqueray, David Delarbre, Hélène Marsaa, Cedric Bergmann, Virginie Da Silva, et al. (+7) Antoine Bronstein, Nicolas Paleiron, Nastasia Menoud, Jacques Cobola, Catherine Verret, Aurélie Mayet, Olivier Bylicki |
32 |
[GO] |
2023―Feb―10 |
Management of imported malaria in the emergency department: adequacy compared to guidelines, and impact of the SARS-CoV-2 pandemic |
C Flateau, A Pitsch, C Cornaglia, M Picque, A de Pontfarcy, P Leroy, et al. (+5) T Jault, C Thach, M Camus, F Dolveck, S Diamantis |
33 |
[GO] |
2023―Jan―23 |
Contributory conditions for unexpected COVID-19 cases and nosocomial COVID-19 infection cases identified from systematic investigation in a French university hospital |
Y. Carré, M. Coppry, C. Bataille, L. Vivier, A. Lasheras-Bauduin, A-M. Rogues |
34 |
[GO] |
2023―Jan―23 |
Towards real-time monitoring of COVID-19 nosocomial clusters using SARS-CoV-2 genomes in a university hospital of the French Alps |
Meghann Gallouche, Caroline Landelle, Sylvie Larrat, Aurélie Truffot, Jean-Luc Bosson, Alban Caporossi |
35 |
[GO] |
2023―Jan―13 |
Outpatient Parenteral Antimicrobial Therapy (OPAT) From an emergency model applied during the COVID-19 pandemic to standard of care: preliminary lessons from our experience |
G. Giuliano, F. Raffaelli, D. Faliero, E. Tamburrini, D. Tarantino, M.C. Nurchis, G. Scoppettuolo |
36 |
[GO] |
2023―Jan―13 |
Association between microbiota and immune response to Sars-CoV-2 infection |
A. Vitiello, A. Zovi, F. Ferrara |
37 |
[GO] |
2022―Dec―13 |
Spread of viruses, which measures are the most apt to control COVID-19? |
Yacine Tandjaoui-Lambiotte, Alexandra Lomont, Pierre Moenne-Locoz, Delphine Seytre, Jean Ralph Zahar |
38 |
[GO] |
2022―Nov―25 |
High-flow cannula for frail patients with SARS-CoV-2 infection non-eligible for intensive care unit management |
L Bouetard, T Flamand, D Vignes, A Robert, R Sterpu, L Lemonnier, et al. (+4) M Mion, V Gerber, S Abgrall, M Martinot |
39 |
[GO] |
2022―Oct―30 |
Prolonged replication of BA.1 and BA.2 Omicron lineages compared to Delta variant in nasopharyngeal samples from COVID-19 patients |
Elisa Teyssou, Stéphane Marot, Theophile Cocherie, Fauchois Antoine, Basma Abdi, Eve Todesco, et al. (+5) Sepideh Akhavan, Valérie Pourcher, Vincent Calvez, Anne-Geneviève Marcelin, Cathia Soulie |
40 |
[GO] |
2022―Sep―22 |
Pharmacovigilance for COVID-19 vaccines: A 1-year experience in France |
S. Crommelynck, P. Thill |
41 |
[GO] |
2022―Sep―21 |
The SARS-CoV-2 vaccines: retrospective and perspectives |
Olivier Epaulard |
42 |
[GO] |
2022―Sep―16 |
From the original SARS-CoV-2 strain to the Omicron variant: predictors of COVID-19 in ambulatory symptomatic children |
R. Cohen, A. Rybak, N. Ouldali, F. Angoulvant, S. Béchet, V Gajdos, et al. (+10) I. Hau, A. Sellam, I. El Aouane El Ghomari, F. Elmerich, C. Batard, A. Auvrignon, E. Grimprel, M. Favier, C. Jung, C. Levy |
43 |
[GO] |
2022―Sep―13 |
What progress has been made in treatment of immunocompromised COVID-19 patients? |
F. Ader, J. Bauer |
44 |
[GO] |
2022―Sep―13 |
Attitudes of French adults toward COVID-19 vaccination |
J.K. Ward, J. Bauer |
45 |
[GO] |
2022―Sep―13 |
Attitudes of healthcare professionals toward the COVID-19 vaccination campaign in France |
J.E. Mueller, J. Bauer |
46 |
[GO] |
2022―Sep―13 |
SARS-CoV-2 seroprevalence and antibodies persistence among health care workers after the first COVID-19 wave in nine hospitals in Western France |
R. Garlantezec, E. Tadié, C. Heslan, P. Gary-Bobo, S. Oumari, A. Saade, et al. (+12) A. Sitruk, P. Tattevin, V. Thibault, C. Paris, Paule Le Deun, Marc Haberbusch, Annie Le Guyader, Gilles Quiboeuf, Yves Le Garzic, Nicolas Chauvel, Laurent Verley, Laetitia Goubert-Fauqueur |
47 |
[GO] |
2022―Sep―13 |
SARS-CoV-2 genetic diversity: Its impact on vaccine efficacy |
B. Lina, J. Bauer |
48 |
[GO] |
2022―Jul―08 |
Incidence and characteristics of COVID-19 in French professional football players during the 2020-2021 season |
D. Luque-Paz, E. Orhant, F. Michel, P. Kuentz, J-F. Chapellier, E. Rolland, et al. (+2) C. Rabaud, P. Tattevin |
49 |
[GO] |
2022―Jul―07 |
Anti-SARS-CoV-2 IgG antibodies in patients with or without SARS-CoV-2 infection after BNT162b2 vaccine booster |
G.L. Salvagno, B.M. Henry, G. Lippi |
50 |
[GO] |
2022―Jun―23 |
Bronchiolitis epidemics in France during the SARS-CoV-2 pandemic: the 2020-2021 and 2021-2022 seasons |
S Vaux, D Viriot, C Forgeot, I Pontais, Y Savitch, A Barondeau-Leuret, et al. (+4) S Smadja, M Valette, V Enouf, I Parent du Chatelet |
51 |
[GO] |
2022―Jun―03 |
Outcome of mild SARS-CoV-2-infected renal transplant recipients managed by supervised home-based self-monitoring |
Vamsidhar Veeranki, Dharmendra Bhadauria, Jeyakumar Meyyappan, Manas Ranjan Patel, Monika Yaccha, Anupma Kaul, et al. (+2) Sabarinath Shanmugam, Narayan Prasad |
52 |
[GO] |
2022―Jun―03 |
The humoral response of mRNA COVID-19 vaccine in hematological diseases: the HEMVACO study |
M Gueguen, L Khatchatourian, C Lohéac, I Dorval, M Mercier, R Le Calloch, et al. (+6) K Mahé, MJ Rizcallah, P Hutin, MS Fangous, N Saidani, L Le Clech |
53 |
[GO] |
2022―May―07 |
Characteristic outcomes and risk assessment of pneumothorax in 21 patients with COVID-19 |
L Pierre, J Rieu, T Lemmet, C Ion, S Gravier, M Mohseni-Zadeh, et al. (+3) T Lawson, V Gerber, M Martinot |
54 |
[GO] |
2022―May―07 |
Teleconsultation in family medicine amid the Covid-19 pandemic: an adequate tool? |
Verhaeghe Hadrien, Nelly Chellum, Benoît Tressières, Rachida Ouissa, Pierre-Marie Roger |
55 |
[GO] |
2022―May―07 |
High-flow nasal oxygen in severe COVID-19 pneumonia and tocilizumab |
M Mandal, M Mazza, A M Esquinas |
56 |
[GO] |
2022―May―02 |
Determinants of the willingness to get the third COVID-19 vaccine dose among health care workers |
C Paris, A Saade, E Tadié, R Nguyen Van, V Turmel, R Garlantezec, P Tattevin |
57 |
[GO] |
2022―Feb―16 |
Association between SARS-Cov-2 infection during pregnancy and adverse pregnancy outcomes: a re-analysis of the data reported by Wei et al. (2021) |
Ludwig Serge Aho Glele, Emmanuel Simon, Camille Bouit, Maeva Serrand, Laurence Filipuzzi, Karine Astruc, et al. (+2) Philippe Kadhel, Paul Sagot |
58 |
[GO] |
2022―Feb―14 |
Successful high flow nasal cannula therapy for severe COVID-19 pneumonia is associated with tocilizumab use |
Rachida Ouissa, Chloé Le Guillou, Marion Broudic, Samuel Markowicz, Elodie Curlier, Pierre-Marie Roger |
59 |
[GO] |
2022―Feb―13 |
Remarkable resolution of COVID-19-associated cerebral vasculitis with methylprednisolone |
S Benguerfi, F Reizine, F Eugène, P Tattevin, A Maamar |
60 |
[GO] |
2022―Feb―13 |
Factors associated with hospital admission and adverse outcome for COVID-19: role of social factors and medical care |
A-L Beaumont, D Vignes, R Sterpu, G Bussone, I Kansau, C Pignon, et al. (+16) R Ben Ismail, M Favier, J-L Molitor, D Braham, R Fior, S Roy, M Mion, L Meyer, M Andronikof, C Damoisel, P Chagué, J-C Aurégan, N Bourgeois-Nicolaos, C Guillet-Caruba, J-P Téglas, S Abgrall |
61 |
[GO] |
2022―Feb―11 |
Long COVID-19 symptoms: clinical characteristics and recovery rate among non-severe outpatients over a six-month follow-up |
S Seang, O Itani, G Monsel, B Abdi, A-G Marcelin, M-A Valantin, et al. (+5) R Palich, A Fayçal, V Pourcher, C Katlama, R Tubiana |
62 |
[GO] |
2022―Feb―08 |
3D-printed simulator for nasopharyngeal swab collection for COVID-19 |
A Koch, M Vermel, Y Hansmann, M Lodi, C Mura, A Sananes, et al. (+14) S Gallien, É Wurtz, A Bleibtreu, M Martinot, J Exinger, X Lescure, S Kerneis, K Lacombe, JY Mootien, C Shawali, L Lecointre, C Debry, N Lefebvre, N Sananes |
63 |
[GO] |
2022―Feb―02 |
Are symptoms associated with SARS-CoV-2 infections evolving over time? |
M. Ricco, M. Valente, F. Marchesi |
64 |
[GO] |
2022―Jan―20 |
COVID-19 reinfection after pregnancy |
L Gobin, A Vallée, D Zucman, M Carbonnel, J Laperrelle, O Brugière, et al. (+3) A Martin, JM Ayoubi, E Farfour |
65 |
[GO] |
2022―Jan―14 |
COVID-19 cluster in vaccinated healthcare workers in Mayotte |
L Mayrand, N Allou, F Colliac Chirié |
66 |
[GO] |
2021―Dec―24 |
Grippe et Covid-19 |
K. Jaffal, H. Mascitti |
67 |
[GO] |
2021―Dec―16 |
Vaccine effectiveness against COVID-19 hospitalization in adults in France: a test negative case control study |
Liem Binh Luong Nguyen, Rebecca Bauer, Zineb Lesieur, Florence Galtier, Xavier Duval, Philippe Vanhems, et al. (+4) Fabrice Lainé, Pierre Tattevin, Christine Durier, Odile Launay |
68 |
[GO] |
2021―Dec―09 |
Pulmonary bacterial infections in adult patients hospitalized for COVID-19 in standard wards |
M Husain, S Valayer, N Poey, E Rondinaud, C d’Humières, B Visseaux, et al. (+3) S Lariven, FX Lescure, L Deconinck |
69 |
[GO] |
2021―Nov―24 |
High negative predictive value of RT-PCR in patients with high likelihood of SARS-CoV-2 infection |
S Galmiche, S Fernandes-Pellerin, MN Ungeheuer, O Schwartz, M Attia, B Hoen |
70 |
[GO] |
2021―Nov―17 |
Prevalence and factors associated with symptom persistence: a prospective study of 429 mild COVID-19 outpatients |
A Faycal, AL Ndoadoumgue, B Sellem, C Blanc, Y Dudoit, L Schneider, et al. (+16) R Tubiana, M-A Valantin, S Seang, R Palich, A Bleibtreu, G Monsel, N Godefroy, O Itani, O Paccoud, V Pourcher, E Caumes, N Ktorza, A Chermak, B Abdi, L Assoumou, C Katlama |
71 |
[GO] |
2021―Nov―11 |
COVID-19 exposure in SARS-CoV-2-seropositive hospital staff members during the first pandemic wave at Strasbourg University Hospital, France |
A Velay, F Gallais, MJ Wendling, S Bayer, N Reix, A Schneider, et al. (+10) L Glady, N Collongues, JM Lessinger, Y Hansmann, L Kling-Pillitteri, J De Sèze, M Gonzalez, C Schmidt-Mutter, N Meyer, S Fafi-Kremer |
72 |
[GO] |
2021―Oct―25 |
Exhaustive assessment of Reunion Island inpatients with COVID-19 during the first wave |
L Bruneau, V Lenclume, A Maillot, A Rousseau, M Lagrange-Xélot, N Allou, P Gérardin |
73 |
[GO] |
2021―Oct―13 |
Evolution of baseline characteristics and severe outcomes in COVID-19 inpatients during the first and second waves in Northeastern France |
M Martinot, M Eyriey, S Gravier, D Kayser, C Ion, M Mohseni-Zadeh, et al. (+3) JC Ongagna, A Schieber, C Kempf |
74 |
[GO] |
2021―Oct―13 |
Demographics and outcomes of laboratory-confirmed COVID-19 cases during the first epidemic wave in Senegal |
Agbogbenkou Tevi Déla-dem Lawson, Mamour Dieng, Fulgence Abdou Faye, Papa Alassane Diaw, Christian Kempf, Adama Berthe, et al. (+3) Madoky Maguette Diop, Martin Martinot, Sylvie Audrey Diop |
75 |
[GO] |
2021―Oct―01 |
Comparison of the first and second waves of coronavirus disease in Toulouse, France |
A. Jourdes, M. Lafaurie, G. Moulis, P. Delobel, M. Faruch, A. Sommet, G. Martin-Blondel |
76 |
[GO] |
2021―Oct―01 |
Lower nasopharyngeal viral load in young SARS-CoV-2-positive subjects |
GL Salvagno, B M Henry, G Lippi |
77 |
[GO] |
2021―Sep―15 |
Multisystem inflammatory syndrome in an adult following COVID-19 |
G Baulier, D Jarnier, B Castan, A Saunier |
78 |
[GO] |
2021―Sep―04 |
Determinants of COVID-19 vaccine hesitancy in French hospitals |
C Navarre, P Roy, S Ledochowski, M Fabre, A Esparcieux, B Issartel, et al. (+8) M Dutertre, A-L Blanc-Gruyelle, F Suy, L Adelaide, C Pariset, JP Kisterman, H Champagne, J Saison |
79 |
[GO] |
2021―Aug―28 |
Chronicles of a pandemic: how France coordinated the scientific research response to COVID-19 |
Erica Telford, Inmaculada Ortega-Perez, Guillaume Mellon, Boris Lacarra, Elisabeth Adjadj, Claire Madelaine, et al. (+2) Eric D’Ortenzio, Yazdan Yazdanpanah |
80 |
[GO] |
2021―Aug―02 |
Consommations hospitalières en antifongiques avant et pendant la première vague de COVID-19 |
F. Lieutier-Colas, A. Jouzeau, A. Chabaud, C. Dumartin, M. Péfau, F. Botterel, et al. (+4) A. Alanio, S. Ranque, J. Gangneux, L. Simon |
81 |
[GO] |
2021―Aug―02 |
La place d’une EOH à l’interface entre les différents acteurs dans le contact tracing COVID-19 |
A. Pyot, A. Provent, M. Poggio, A. Fourneret-Vivier, E. Forestier, F. Mallaval |
82 |
[GO] |
2021―Aug―02 |
Les engelures : un facteur pronostique associé à moins d’hospitalisations pour COVID-19 |
H. Mascitti, P. Jourdain, A. Bleibtreu, L. Jaulmes, A. Dechartres, X. Lescure, et al. (+2) Y. Yordanov, A. Dinh |
83 |
[GO] |
2021―Aug―02 |
Surinfection bactérienne chez les patients hospitalisés pour COVID-19 |
S. Ben Hmida, I. Bougharriou, S. Ourida, K. Mnif, T. Ben Jemaa, K. Rekik, et al. (+4) F. Smaoui, M. Koubaa, C. Marrakchi, M. Ben Jemaa |
84 |
[GO] |
2021―Aug―02 |
Surmortalité dans les maisons de retraite pendant la pandémie de COVID-19 |
S. Bessis, A. Schnitzler, H. Mascitti, C. Duran, A. Dinh |
85 |
[GO] |
2021―Aug―02 |
Mise en place des centres de vaccination contre la COVID-19 |
G. Mellon, J.M. Chapplain, F. Chatel, H. Coignard, C. Migerel, F.X. Lescure |
86 |
[GO] |
2021―Aug―02 |
« Pandecomics » : l’apport de la bande dessinée à l’ère du COVID-19 |
M. Puges, D. Neau, J.L. Pellegrin, P. Parneix, A.M. Rogues, M.E. Lafon, et al. (+4) Y. Belaroussi, T. Le Roux, F. Guerville, C. Cazanave |
87 |
[GO] |
2021―Aug―02 |
« Coronaaah, c’est quoi ? » : une bande dessinée de vulgarisation scientifique sur le COVID-19 |
M. Puges, D. Neau, J.L. Pellegrin, M. Begon, A.M. Rogues, M.E. Lafon, et al. (+4) D. Malvy, P. Blanco, P. Parneix, C. Cazanave |
88 |
[GO] |
2021―Aug―02 |
SYNDICORO. Implication des SMIT français dans la 1re phase de l’épidémie de COVID-19 |
C. Casas, S. Alfandari, P. Abgueguen, D. Salmon, B. Wyplosz, H. Aumaître |
89 |
[GO] |
2021―Aug―02 |
Caractéristiques des volontaires inscrits sur la plateforme nationale dédiée aux essais vaccinaux COVID-19 |
J. Sambourg, M. Bonneton, L. Luong, C. Trillou, T. Ngoué, J. Dohou, et al. (+4) M. Schuers, M. Lachâtre, N. Lenzi, O. Launay |
90 |
[GO] |
2021―Aug―02 |
Oxygénothérapie à haut débit en hospitalisation conventionnelle de maladies infectieuses au temps de la CoVID-19 |
C. Badr, D. Jaafar, A. Bounhiol, F. Medina, J. Georger, P. Caraux-Paz |
91 |
[GO] |
2021―Aug―02 |
Maladie à Coronavirus (COVID-19) : connaissance, attitude et pratiques du personnel de santé |
S. Boujamline, W. Marrakchi, I. Kooli, M. Abdeljalil, H. Ben Brahim, A. Toumi, et al. (+2) A. Aouam, M. Chakroun |
92 |
[GO] |
2021―Aug―02 |
Émergence de variants E484 K suite à une monothérapie bamlanivimab chez des patients COVID-19 à haut risque d’évolution vers une forme sévère |
N. Peiffer-Smadja, A. Bridier-Nahmias, C. Carpentier, M. Garé, C. Rioux, A. Allemand, et al. (+4) L. Kramer, D. Descamps, Y. Yazdanpanah, B. Visseaux |
93 |
[GO] |
2021―Aug―02 |
Covid-19 à La Réunion : peut-on parler d’un « confinement des pathologies » pour les passages aux urgences et les consultations en médecine libérale en 2020 ? |
J. Daoudi, M. Vincent, A. Vague, B. Guihard, I. Pontais, L. Menudier |
94 |
[GO] |
2021―Aug―02 |
Covid-19 à Mayotte : profil épidémiologique d’une année de crise |
M. Subiros, F. Parenton, R. Blonde, F. Pousset, A. Diallo, M. Niang, et al. (+4) A. Chamouine, L. Iche, L. Collet, P. Combe |
95 |
[GO] |
2021―Aug―02 |
Évolution du taux de recours à l’antibiothérapie chez les patients hospitalisés pour COVID-19 - ANTIBIOVID 2 |
A. Thery, A. Galy, R. Lepeule, C. Ourghanlian |
96 |
[GO] |
2021―Aug―02 |
Comparaison des caractéristiques et de l’évolution des patients hospitalisés pour COVID-19 au cours de la première et deuxième vagues en France |
M. Martinot, M. Eyrier, S. Gravier, D. Kayser, C. Ion, M. Mohseni-Zadeh, et al. (+4) J. Onganga, J. Kaiser, A. Schieber, C. Kempf |
97 |
[GO] |
2021―Aug―02 |
Transmission de la COVID-19 aux agents de santé : oé est le risque ? |
A. Lomont, N. Hassold, H. Delagreverie, S. O믪, S. Nagle, C. Alloui, et al. (+2) J. Zahar, H. Cordel |
98 |
[GO] |
2021―Aug―02 |
Évaluation de l’impact de la pandémie de la COVID-19 chez les patients vivants avec le VIH |
L. Bronner, O. Robineau, F. Ajana, T. Huleux, J.L. Schmit, J.P. Lanoix, et al. (+4) H. Bazus, E. Aissi, A. Meybeck, P. Thill |
99 |
[GO] |
2021―Aug―02 |
Le fardeau de la COVID-19 chez les personnes vivant avec le VIH après la première vague de la pandémie |
A. Meybeck, T. Huleux, M. Tétart, P. Thill, V. Derdour, L. Bocket, et al. (+4) E. Alidjinou, P. Patoz, O. Robineau, F. Ajana |
100 |
[GO] |
2021―Aug―02 |
Étude multicentrique des déterminants à la vaccination COVID-19 chez les travailleurs hospitaliers, en établissements publics et privés |
C. Navarre, M. Fabre, A. Esparcieux, B. Issartel, M. Dutertre, A. Blanc-Gruyelle, et al. (+4) F. Suy, L. Adelaide, H. Champagne, J. Saison |
101 |
[GO] |
2021―Aug―02 |
Spécificités des pneumopathies acquises sous ventilation mécanique chez les patients atteints de COVID-19 (CPAVM) : comparaison avec une cohorte historique de PAVM non COVID (NCPAVM) |
M. Rouyer, T. Youbong, A. Strazzulla, P. Leroy, A. Pitsch, C. Judel, et al. (+4) B. Cassard, S. Jochmans, M. Monchi, S. Diamantis |
102 |
[GO] |
2021―Aug―02 |
Consommations d’antibiotiques pendant la première vague COVID-19 dans les établissements de santé |
A. Jouzeau, A. Chabaud, M. Péfau, L. Dugravot, F. Lieutier-Colas, L. Simon, C. Dumartin |
103 |
[GO] |
2021―Aug―02 |
Gestion de la pandémie COVID-19 dans les établissements scolaires : est ce que les enseignants respectent les bonnes pratiques d’hygiène ? |
N. Ketata, H. Ben Ayed, I. Masmoudi, S. Yaich, M. Baklouti, M. Al Belbissi, et al. (+3) M. Kassis, H. Feki, J. Damak |
104 |
[GO] |
2021―Aug―02 |
Création d’une équipe de coordination dédiée à la vaccination Covid-19 dans les communes isolées de Guyane |
E. Jacoud, S. Teissier, V. Servas, A. Papin, F. Morandais, F. Gras, et al. (+4) C. Michaud, M. Gaillet, N. Vignier, L. Epelboin |
105 |
[GO] |
2021―Aug―02 |
Difficultés et enjeux de la vaccination contre le COVID-19 dans une Guyane multiethnique et multiculturelle |
L. Epelboin, C. Michaud, B. Bidaud, L. Dudognon, C. Cochet, C. Caspar, et al. (+4) E. Jacoud, V. Servas, N. Vignier, M. Gaillet |
106 |
[GO] |
2021―Aug―02 |
Attitudes vis-à-vis du vaccin COVID-19 des soignants exerçant en Guyane française |
N. Vignier, K. Brureau, S. Granier, J. Breton, C. Agostini, L. Epelboin, et al. (+4) A. Valdes, P. Abboud, F. Djossou, M. Douine |
107 |
[GO] |
2021―Aug―02 |
Présentation clinique, survie et facteurs associés à la mortalité: une étude prospective dans trois centres COVID-19 en Afrique de l’Ouest |
M. Jaspard, M. Saliou Sow, S. Juchet, E. Dienderé, B. Serra, R. Kojan, et al. (+4) A. Poda, S. Keita, X. Anglaret, D. Malvy |
108 |
[GO] |
2021―Aug―02 |
COVID-19 et étudiants en médecine : connaissances, attitudes et pratiques |
N. Ketata, H. Ben Ayed, M. Ben Hmida, M. Trigui, M. Ben Jmeaa, S. Yaich, et al. (+3) M. Kassis, H. Feki, J. Damak |
109 |
[GO] |
2021―Aug―02 |
MicroARN en tant que biomarqueurs de la COVID-19 grave |
S. Menasria, J. Poissy, B. Guerred, M. Caplan, J. Goutay, J. Labreuche, et al. (+4) F. Soncin, D. Hober, S. Szunerits, I. Engelmann |
110 |
[GO] |
2021―Aug―02 |
Analyse des consommations locales d’antibiotiques durant la première vague épidémique de COVID-19 (mars-avril 2020) dans un hôpital de référence |
L. Roquefeuil, C. Lawrence, A. Dinh, P. Bravo, M. Villart, B. Davido, F. Bouchand |
111 |
[GO] |
2021―Aug―02 |
La communication destinée aux professionnels de santé au cœur de la gestion de crise de la pandémie de COVID-19 par le ministère des Solidarités et de la Santé |
M. Rigaud, L. Prevost Sansac de Traversay, M. Creach, C. Lazarus, J. Salomon |
112 |
[GO] |
2021―Aug―02 |
Forme sévère de COVID-19 pendant la première vague épidémique en France : rôle des facteurs sociaux et des traitements empiriques |
A. Beaumont, D. Vignes, R. Sterpu, S. Roy, C. Guillet-Caruba, J. Téglas, S. Abgrall |
113 |
[GO] |
2021―Aug―02 |
Mise en relation entre l’évolution clinique et scanographique des patients atteints de la COVID-19 sévère ou critique traités par glucocorticoïdes |
A. Courdurié, M. Juston, P. Foglino, E. Demonchy |
114 |
[GO] |
2021―Aug―02 |
Impact de l’épidémie de COVID-19 sur la couverture vaccinale antigrippale du personnel hospitalier |
A. Gronnwald, V. Gerber, C. Hommel, D. Eckenfelder, O. Meunier, A. Sondag, et al. (+3) P. Lefebvre, M. Martinot, M. Mohseni-Zadeh |
115 |
[GO] |
2021―Aug―02 |
Bilan des signalements COVID-19 sur la plateforme e-SIN, France, 2020 |
P. Toulemonde, I. Poujol, S. Soing-Altrach, A. Léon, A. Berger-Carbonne |
116 |
[GO] |
2021―Aug―02 |
Impact de la pandémie de COVID-19 sur la résistance aux antibiotiques en soins de ville et en Ehpad en France |
O. Lemenand, T. Coeffic, S. Thibaut, J. Caillon, G. Birgand |
117 |
[GO] |
2021―Aug―02 |
Influence de la pandémie de la COVID-19 sur le dépistage de l’infection par le VIH |
O. Da Conceicao, M. Digumber, S. Le Gac, B. Phung, A. Bachard, R. Landman, et al. (+4) F. Damond, J. Ghosn, Y. Yazdanpanah, V. Joly |
118 |
[GO] |
2021―Aug―02 |
Impact post-déconfinement de la pandémie de COVID-19 sur les patients chroniques en Europe |
A. Astruc, B. Halioua, J. Zetlaoui, M. Harrizi, A. Bombezin-Domino, L. Radoszycki |
119 |
[GO] |
2021―Aug―02 |
Impact de la pandémie de COVID-19 sur les populations sans domicile fixe : résultats d’une cohorte fermée rétrospective (mars-mai 2020) |
M. Husain, A. Rachline, A. Cousien, S. Rolland, V. Ferre, M. Wicky-Thisse, et al. (+4) D. Descamps, Y. Yazdanpanah, C. Charpentier, A. Pasquet-Cadre |
120 |
[GO] |
2021―Aug―02 |
Impact de la pandémie à COVID-19 sur les voyages internationaux |
K. Jidar, G. Benabdelmoumen, C. Lucet, P. Poujol, L. Kuhmel, J. Leporrier, P. Consigny |
121 |
[GO] |
2021―Aug―02 |
Suivi ambulatoire des patients COVID-19 via l’application MH LINK |
A. Martin, E. Nogue, M. Morell, J. Reynes, V. Le Moing, M. Picot, A. Makinson |
122 |
[GO] |
2021―Aug―02 |
Intérêt du passage précoce d’un référent infectieux sur l’exposition aux antibiotiques des patients hospitalisés pour COVID-19 - ANTIBIOVID |
A. Galy, C. Ourghanlian, S. Fourati, S. Gallien, G. Melica, W. Vindrios, et al. (+4) C. Guillaud, V. Fihman, M. Harrabi, R. Lepeule |
123 |
[GO] |
2021―Aug―02 |
Consommation d’antibiotiques à l’ère de la COVID-19 : analyse et comparaison entre la 1re et 2e vague |
C. Meunier, D. Neau, M. Puges, C. Cazanave, A. Desclaux |
124 |
[GO] |
2021―Aug―02 |
Prévention COVID-19 : du dépistage à la vaccination « hors les murs (HLM) » |
M. Ruffin, M. Roy, A. Eden, J. Cornaglia, H. Aumaître |
125 |
[GO] |
2021―Aug―02 |
Pneumopathies acquises sous ventilation mécanique (PAVM) chez les patients atteints de COVID-19 : facteurs associés à la mortalité |
M. Rouyer, T. Youbong, A. Strazzulla, P. Tarteret, S. Devatine, A. Pitsch, et al. (+4) B. Cassard, S. Jochmans, M. Monchi, S. Diamantis |
126 |
[GO] |
2021―Aug―02 |
Gestion de la COVID-19 : perceptions et expériences des personnels de nuit lors de la première vague de la pandémie dans les hôpitaux publics parisiens (enquête AP-HP ALADDIN) |
M. Duracinsky, L. Cousin, O. Rousset Torrente, V. Di Beo, V. Mahé, P. Carrieri, et al. (+2) F. Marcellin, O. Chassany |
127 |
[GO] |
2021―Aug―02 |
Évaluation de l’efficacité d’une stratégie multimodale sur les connaissances et les perceptions des professionnels de santé en matière d’hygiène des mains en phase pandémique COVID-19 : une étude quasi-expérimentale |
H. Maamri, H. Ben Ayed, N. Ketata, M. Baklouti, S. Yaich, H. Feki, J. Damak |
128 |
[GO] |
2021―Aug―02 |
Les patients infectés par le VIH sont-ils défiants vis-à-vis de la vaccination COVID-19 ? |
M.A. Khuong-Josses, C. Charpentier, M. Poupard |
129 |
[GO] |
2021―Aug―02 |
Quelles particularités des manifestations digestives de la COVID-19 ? |
K. Mnif, F. Smaoui, S. Ben Hmida, H. Hana Chaabouni, F. Gassara, K. Rekik, et al. (+3) M. Koubaa, C. Marrakchi, M. Ben Jemaa |
130 |
[GO] |
2021―Aug―02 |
Présentation clinique des patients présentant des symptômes persistants après un épisode documenté ou non documenté d’infection par le SARS-CoV-2 |
D. Slama, M. Ben Azaiez, O. Robineau, V. Le Baut, T. de Broucker, C. Hautefort, et al. (+2) E. Pichard, D. Salmon |
131 |
[GO] |
2021―Aug―02 |
EndoNUclease Heteroduplex Cleavage typing (ENUHCT) : une technique universelle de typage avec concept de preuve sur la détection des variants de spike du SARS-CoV-2 |
E. Lopez, B. Coutard, B. Lina, A. Falchi, X. de Lamballerie, R. Charrel |
132 |
[GO] |
2021―Aug―02 |
Facteurs associés à l’infection par le SARS-CoV-2, étude de cohorte de personnes en situation de sans-abrisme |
E. Mosnier, S. Loubière, E. Monfardini, A. Alibert, J. Landier, L. Ninoves, et al. (+4) T. Bosetti, M. Mosnier, S. Nguengang Wakap, A. Tinland |
133 |
[GO] |
2021―Aug―02 |
Séroprévalence SARS-CoV-2 au Mali : résultats d’une enquête transversale |
M. Cissoko, J. Landier, M. Bendiane, A. Sangaré, A. Katile, I. Berthé, et al. (+4) I. Théra, B. Kouriba, J. Gaudart, I. Sagara |
134 |
[GO] |
2021―Aug―02 |
Réponse à la vaccination contre le SARS-CoV-2 chez des patients hémodialysés chroniques |
M. Monge, C. Richaud, M. De Laroche, M. Lefevre, S. Camps, F. Compain |
135 |
[GO] |
2021―Aug―02 |
Étude de l’expression du CD169 sur les monocytes comme biomarqueurs des infections virales notamment le SARS-CoV-2 chez l’enfant |
L. Domitien, A. Bedin, E. Tuaillon, E. Jeziorski |
136 |
[GO] |
2021―Aug―02 |
Séroprévalence SARS-Cov-2 chez les professionnels de santé : étude multicentrique avec analyse des facteurs de risque professionnels et extraprofessionnels |
V. Vitrat, A. Maillard, A. Raybaud, C. Wackenheim, B. Chanzy, S. Nguyen, et al. (+4) A. Valran, A. Bosch, M. Noret, T. Delory |
137 |
[GO] |
2021―Aug―02 |
Persistance et protection des anticorps neutralisants 12 mois après l’infection à SARS-COV-2 chez les sujets âgés |
R. Collarino, C. Vauloup-Fellous, A. Allemang-Trivalle, L. Mouna, E. Duron, M. Neiss, et al. (+4) Z. Trikha, M. Guichardon, A. Roque, C. Trivalle |
138 |
[GO] |
2021―Aug―02 |
Dépistage du personnel de santé exposé au SARS-CoV-2 dans un hôpital universitaire |
L. Noel, E. Marion, R. Boufercha, F. Martin, C. Zandotti, R. Charrel, et al. (+3) M. Bouhadfane, M. Lehucher-Michel, A. Villa |
139 |
[GO] |
2021―Aug―02 |
Optiflow® et SARS-CoV-2 en réanimation : facteurs de risque de recours à la ventilation mécanique et devenir des patients |
X. Leroux, M. Schock, H. Lessire, C. Bouterra, L. Belilita, P. Rerat, et al. (+3) M. Martinot, A. Alvarez, V. Gerber |
140 |
[GO] |
2021―Aug―02 |
Pneumothorax et SARS-CoV-2 : analyse rétrospective de 18 cas |
L. Pierre, V. Gerber, J. Rieu, T. Lemmet, C. Ion, D. Kayser, et al. (+2) S. Gravier, M. Martinot |
141 |
[GO] |
2021―Aug―02 |
Des conditions hivernales froides et sèches favorisent la transmission du SARS-CoV-2 : une analyse régionale de la première vague dans six pays occidentaux |
J. Landier, J. Paireau, S. Rebaudet, E. Legendre, L. Lehot, A. Fontanet, et al. (+2) S. Cauchemez, J. Gaudart |
142 |
[GO] |
2021―Aug―02 |
Caractéristiques cliniques et devenir des patients de 75 ans et plus patients atteints d’une infection à SARS-CoV2 |
J. Mabile, E. Bernachon, A. Markiewicz, R. Hequette |
143 |
[GO] |
2021―Aug―02 |
Professionnels en établissements de santé infectés par le SARS-COV2 : le bilan après un an de pandémie |
G. Ben Hmidene, M. Colomb-Cotinat, S. Vaux, C. Olivier, N. Floret, F. Golliot, et al. (+4) G. Pellissier, E. Rouveix, D. Abiteboul, A. Berger-Carbonne |
144 |
[GO] |
2021―Jul―28 |
Herpesvirus reactivation during severe COVID-19 and high rate of immune defect |
A Saade, G Moratelli, E Azoulay, M Darmon |
145 |
[GO] |
2021―Jul―13 |
Assessment of SARS-CoV-2 testing in children during a low prevalence period (VIGIL study 1) |
Eleonore Eskander, Camille Jung, Corinne Levy, Stéphane Béchet, Nathalie Blot, Stéphanie Gorde, et al. (+4) Camille le Stradic, Matthieu Come, Robert Touitou, Robert Cohen |
146 |
[GO] |
2021―Jul―07 |
Predictors of mortality, ICU hospitalization, and extrapulmonary complications in COVID-19 patients |
M Martinot, M Eyriey, S Gravier, T Bonijoly, D Kayser, C Ion, et al. (+9) M Mohseni Zadeh, S Camara, J Dubois, E Haerrel, J Drouaine, J Kaiser, JC Ongagna, A Schieber-Pachart, C Kempf |
147 |
[GO] |
2021―Jul―07 |
Burden of COVID-19 on workers in hospital settings: the French situation during the first wave of the pandemic |
M. Colomb-Cotinat, I. Poujol, S. Monluc, S. Vaux, C. Olivier, S. Le Vu, et al. (+4) N. Floret, F. Golliot, A. Berger-Carbonne, the Geres-study group |
148 |
[GO] |
2021―Jul―06 |
Is the second dose of vaccination useful in previously SARS-CoV-2-infected healthcare workers? |
G Pean De Ponfilly, B Pilmis, I El Kaibi, N Castreau, S Laplanche, A Le Monnier |
149 |
[GO] |
2021―Jun―29 |
Tocilizumab and COVID-19: timing of administration assessment |
Q Richier, V Jachiet, V Bonnemains, L Plaçais, N Abisror, M Garnier, et al. (+8) J Pacanowski, R Dhote, O Hinchschberger, M Michel, B Bienvenu, C Comarmond, K Lacombe, A Mekinian |
150 |
[GO] |
2021―Jun―17 |
Analysis of endogenous oxidative damage markers and association with pulmonary involvement severity in patients with SARS-CoV-2 pneumonia |
Hanifi Yildiz, Hamit Hakan Alp, Selami Ekin, Ahmet Arisoy, Hülya Günbatar, Selvi Aşker, et al. (+7) Buket Mermit Çilingir, Aysel Sünnetcioğlu, Maşuk Çelikel, Nevzat Esen, Serhat Bedirhanoğlu, Delal Nuruban Baykal, Mine Haylu |
151 |
[GO] |
2021―Jun―16 |
Are the conditions met to make COVID-19 vaccination mandatory for healthcare professionals? |
Amandine Gagneux-Brunon, Elisabeth Botelho-Nevers, Odile Launay |
152 |
[GO] |
2021―May―21 |
How can SARS-CoV-2 airborne transmission ensure effective protection of healthcare workers? A review of the literature |
Sara Romano-Bertrand, Yolène Carré, Ludwig-Serge Aho Glélé, Didier Lepelletier |
153 |
[GO] |
2021―May―14 |
Broad-based SARS-CoV-2 Testing Program for Healthcare Workers in a Primary Care Hospital In France |
Julie Chas, Marine Nadal, Martin Siguier, Anne Fajac, Michel Denis, Laurence Morand-Joubert, Gilles Pialoux |
154 |
[GO] |
2021―May―12 |
Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? |
Robert Cohen, Marion Ashman, Muhamed-Kheir Taha, Emmanuelle Varon, François Angoulvant, Corinne Levy, et al. (+4) Alexis Ryback, Naim Ouldali, Nicole Guiso, Emmanuel Grimprel |
155 |
[GO] |
2021―May―05 |
COVID-19 vaccine hesitancy among healthcare workers |
Christophe Paris, François Bénézit, Mareva Geslin, Elisabeth Polard, Marion Baldeyrou, Valérie Turmel, et al. (+3) Émilie Tadié, Ronan Garlantezec, Pierre Tattevin |
156 |
[GO] |
2021―Mar―27 |
Screening around a COVID-19 cluster: Exploring its impact on a local virus outbreak |
Gaelle Gault, Olivier Monpierre, Gaetane Carion, Patrick Rispal, Helene Royer, Marie-Edith Lafon, et al. (+2) Daniel Habold, Laurent Filleul |
157 |
[GO] |
2021―Mar―23 |
Olfactory and gustatory dysfunctions in COVID-19 outpatients: a prospective cohort study |
L. Cousyn, B. Sellem, R. Palich, D. Bendetowicz, R. Agher, C. Delorme, et al. (+10) R. Tubiana, M-A. Valantin, S. Seang, L. Schneider, A. Fayçal, Y. Dudoit, B. Abdi, A. Ndoadoumgue, L. Assoumou, C. Katlama |
158 |
[GO] |
2021―Mar―19 |
Outcomes of newborns to mothers with COVID-19 |
K Ghema, M Lehlimi, H Toumi, A Badre, M Chemsi, A Habzi, S Benomar |
159 |
[GO] |
2021―Mar―14 |
Bridging the gap between scientific discovery and clinical application during the COVID-19 epoch |
Boris Lacarra, Guillaume Mellon, Inmaculada Ortega Perez, Eric D’Ortenzio, François-Xavier Lescure |
160 |
[GO] |
2021―Mar―14 |
Mosaic vaccination schedule: an unexpected card to play against SARS-CoV-2? |
Ricco Matteo, De Nard Francesca, Peruzzi Simona |
161 |
[GO] |
2021―Feb―27 |
Covid-19 vaccines: frequently asked questions and updated answers |
M. Lefebvre, N. Vignier, B. Pitard, E. Botelho-Nevers, R. Cohen, O. Epaulard |
162 |
[GO] |
2021―Feb―07 |
Clinical case definition of COVID-19 and morbid obesity: Is it time to move on? |
Valente Marina, Ricco Matteo, Tartamella Francesco, Petracca Gabriele Luciano, Dalmonte Giorgio, Fabbi Diletta, Marchesi Federico |
163 |
[GO] |
2021―Feb―07 |
BCG vaccination and COVID-19: Was flattening the curve just an illusion? |
Matteo Ricco, Silvia Ranzieri |
164 |
[GO] |
2021―Jan―27 |
Mixed mold infection with Aspergillus fumigatus and Rhizopus microsporus in a Severe Acute Respiratory syndrome Coronavirus 2 (SARS-CoV-2) patient |
Anne-Pauline Bellanger, Jean-Christophe Navellou, Quentin Lepiller, Annie Brion, Anne-Sophie Brunel, Laurence Millon, Ana Berceanu |
165 |
[GO] |
2021―Jan―22 |
COVID-19: The Forgotten Cases of Hidden Exiles |
Clément Le Bihan, Vincent Faucherre, Vincent Le Moing, Aurélie Mehenni, Damien Nantes, Antonio Da Silva, et al. (+3) Cyril Jaume, Fabienne Lassalle, Alain Makinson |
166 |
[GO] |
2021―Jan―19 |
Clinical, biological and radiological features, 4-week outcomes and prognostic factors in COVID-19 elderly inpatients |
R. Palich, Y. Wakim, O. Itani, O. Paccoud, S. Boussouar, M. Lévy-Soussan, et al. (+3) C. Soulie, N. Godefroy, A. Bleibtreu |
167 |
[GO] |
2021―Jan―19 |
The Role of Infectious Disease trainees during the first wave of the COVID-19 pandemic: a national survey |
Kevin Bouiller, Gaud Catho, Marion Le Maréchal, Julien Gras, Maxime Hentzien, Nathan Peiffer-Smadja |
168 |
[GO] |
2021―Jan―19 |
Invasive Aspergillosis Associated with severe COVID-19: A Word of Caution |
Laura Gouzien, Theophile Cocherie, Odile Eloy, Stéphane Legriel, Jean-Pierre Bedos, Christelle Simon, et al. (+3) Stephanie Marque-Juillet, Alexis Ferré, Fabrice Bruneel |
169 |
[GO] |
2021―Jan―19 |
Psychological impact of the SARS-CoV-2 outbreak on the staff of a French hospital |
C. Flateau, C. Noël, A. Bonnafoux, E. Fuentes, A de Pontfarcy, S. Diamantis |
170 |
[GO] |
2021―Jan―19 |
Novel pathogens, same old habits. A call for evidence-based research in the fight against COVID-19 |
Claudio Legnani, Claudio Legnani, Elisa Dusi |
171 |
[GO] |
2021―Jan―19 |
High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically-ill patients with Covid-19 |
Arthur Simonnet, Ilka Engelmann, Anne-Sophie Moreau, Bruno Garcia, Sophie Six, Ahmed El Kalioubie, et al. (+3) Laurent Robriquet, Didier Hober, Mercé Jourdain |
172 |
[GO] |
2021―Jan―19 |
Do not neglect SARS-CoV-2 hospitalization and fatality risks in the middle-aged adult population |
Nathanael Lapidus, Juliette Paireau, Daniel Levy-Bruhl, Xavier de Lamballerie, Gianluca Severi, Mathilde Touvier, et al. (+3) Marie Zins, Simon Cauchemez, Fabrice Carrat |